Contact HCVHome

Former Portfolio Companies

Healthcare Ventures has made investments through eight major funds. We are currently making new investments in Focused Companies through HealthCare Ventures IX. The links below list companies were we are active, and companies we have worked with in the past, along with links to their websites, where available.

Former Portfolio Companies, Printer Friendly

ActivBiotics
Antibacterials/Infectious Disease

Allegiant Physician Services
Management of Hospital Anesthesia Departments

Allergy Clinics of America
Allergy Practice Management
Sold to Vivra

Arresto BioSciences
Cancer and Fibrotic Disease
Sold to Gilead Sciences, Inc.

ASC Network
Operation of Ambulatory Surgery Centers
Sold to HealthSouth

Aton Pharma
Cancer
Sold to Merck

Avant Immunotherapeutics
Vaccines

Avidia
Develops Human Therapeutic Proteins
Sold to Amgen

BioTransplant
Organ Transplantation

CardioKine
Cardiovascular
Sold to Cornerstone Therapeutics, Inc.

Cornerstone Therapeutics
Emergency Medicine

CytoMed
Inflammatory & Immunologic Pharmaceuticals
Sold to Leukosite

Delsys Pharmaceutical
Drug Formulation & Manufacture
Sold to Elan

Dendreon
Cancer

Diacrin
Cellular Therapy
Acquired by GenVec

Differential Diagnostics
Clinical Laboratories

Dyax Corp.
Biotherapeutics & Discovery Technologies

Dynogen Pharmaceuticals
GI/GU

Endomedix
Products for Minimally Invasive Surgery

FoldRx Pharmaceuticals
Protein Folding Disorders
Sold to Pfizer, Inc.

GelTex Pharmaceuticals
Binding Resins
Sold to Genzyme after HCV sold all of it's holding.
HCV had no association with them at time of sale.

Genaera
Anti-Infectives & Cancer Therapeutics

Genetic Therapy
Gene Therapy
Sold to Novartis

GenVec
Cancer, Cardiovascular, Ophthalmic

GynoPharma
Gynecological Products
Sold to Johnson & Johnson

HealthSynq
Health Care Cost Containment

Human Genome Sciences
Genomics

Integrity Pharmaceutical
Specialty Pharma/Women's Health

Leukosite
Cancer, Inflammatory & Autoimmune
Acquired by Millennium Pharmaceuticals

Lukens Medical
Sutures

MediGene
Clinical Genetics Laboratories
Sold to Genzyme

MedImmune
Vaccines & Immunotherapeutics
Sold to AstraZeneca

Memory Pharmaceuticals
CNS

Metaphore Pharmaceuticals
Pain & Inflammation
Acquired by ActivBiotics

MiddleBrook Pharmaceuticals
Antibacterials/Antifungals/Infectious Disease

Millennium Healthcare
Managed Care Information Systems and Software

Molecular Oncology
Cancer Therapeutics
Acquired by Aronex Pharmaceuticals

More.com
e-commerce Drug Store/Nutritionals

National Pain Institute
Outpatient Pain Management Services
Sold to Allegiant Physician Services

NitroMed
Cardiovascular

Novazyme Pharmaceuticals
Lysosomal Storage Disease
Acquired by Genzyme Corporation

OraSure Technologies
Oral Fluid Testing

Oriel Therapeutics
Pulmonary Drug Delivery
Sold to Sandoz, Inc.

Orqis Medical
Cardiovascular

Osteoarthritis Sciences
Connective Tissue Disorders

OsteoTech
Orthopedics

Pediatric Pharmaceuticals
Pediatric Products
Acquired by MedImmune

PeptiMed
GI

PharmaGenics
Cancer
Acquired by Genzyme Molecular Oncology

Pharmavene
CNS/Infectious Disease/Cancer/
     Metabolic/Cardiovascular
Acquired by Shire Pharmaceuticals Group

Potentia Pharmaceuticals
Macular Degeneration

Premier Pharmacy
Operation of Hospital-based Pharmacies
Sold to Choice Drug

Principia Pharmaceutical
Drug Delivery
Acquired by Human Genome Sciences

Procept
Immunology

Progen Pharmaceuticals
Cancer

ProScript
Proteasome Inhibitors
Sold to Leukosite

Sequoia Pharmaceuticals
Infectious Disease

Shire Pharmaceuticals Group
Specialty Pharmaceuticals Group

Sierra Neuropharmaceuticals
Brain Disease

STC Technologies
Acquired by OraSure Technologies

Thios Pharmaceuticals
Immunology

3-Dimensional Pharmaceuticals
Cardiovascular & Discovery Technology
Sold to Johnson & Johnson

Tolerx
Immunology

Trophix Pharmaceuticals
Neurology & Protein-based Drug Discovery
Acquired by NPS Pharmaceuticals

Upstate Group
Research Reagents
Acquired by Serologicals Corporation

Verenium
Industrial Enzymes/Biotherapeutics

Vicuron Pharmaceuticals
Antibacterials/Antifungals/Infectious Disease
Sold to Pfizer

Visionary Therapeutics
Ophthalmology

Back to top